3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Lung Neoplasms
3
Breast Neoplasms
3
Neuroendocrine Tumors
2
Respiratory Insufficiency
1
Radiation Pneumonitis
1
Prostatic Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lung Diseases
1
Hodgkin Disease
1
Endometrial Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Abnormalities, Radiation-Induced
1
Interventions
Carboplatin
10
Paclitaxel
5
Nivolumab
4
Pemetrexed
3
Cisplatin
3
atezolizumab
2
apatinib
2
Surveys and Questionnaires
2
One-Lung Ventilation
2
Ipilimumab
2
Blood Specimen Collection
2
Bevacizumab
2
zimberelimab
1
toripalimab
1
spartalizumab
1
sitravatinib
1
sintilimab
1
sacituzumab govitecan
1
pembrolizumab
1
lorlatinib
1
cemiplimab
1
camrelizumab
1
Vital Signs
1
Vinorelbine
1
Tyrosine Kinase Inhibitors
1
Tomography, Emission-Computed, Single-Photon
1
Temozolomide
1
Telescopes
1
Talc
1
Saline Solution
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Lung Diseases
×
Tomography, Emission-Computed, Single-Photon
×
Clear all
NCT04676828
2026-02-24
ASPECT
University of Aarhus
Phase NA
Recruiting
90 enrolled